Ossiam Has $12.03 Million Stock Holdings in Stryker Corporation $SYK

Key Points

• Ossiam raised its stake in Stryker by 379% in Q3 to 32,531 shares, valued at about $12.03 million.
• Stryker has confirmed a cybersecurity incident disrupting orders, manufacturing and shipments, with hackers claiming destructive “wiper” activity and the stock seeing multi‑percent declines amplified by social‑media selling.
• Director Ronda E. Stryker sold 250,000 shares for roughly $90.73 million on Feb. 4 (a 9.23% reduction); insiders own about 5.9% while institutions hold ~77.1% of the company.

Ossiam raised its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 379.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 32,531 shares of the medical technology company's stock after acquiring an additional 25,739 shares during the period. Ossiam's holdings in Stryker were worth $12,026,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in shares of Stryker during the second quarter worth $1,882,173,000. Alliancebernstein L.P. lifted its stake in Stryker by 307.6% in the second quarter. Alliancebernstein L.P. now owns 5,596,508 shares of the medical technology company's stock valued at $2,214,146,000 after buying an additional 4,223,366 shares during the period. Corient Private Wealth LLC boosted its holdings in Stryker by 104.4% during the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company's stock worth $887,525,000 after buying an additional 1,146,998 shares during the last quarter. Strive Asset Management LLC bought a new position in Stryker during the third quarter worth about $227,389,000. Finally, ABN AMRO Bank N.V. acquired a new position in shares of Stryker during the 2nd quarter worth about $191,047,000. Institutional investors and hedge funds own 77.09% of the company's stock.

More Stryker News

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Citi and some analysts view the pullback as a potential buying opportunity given Stryker’s fundamentals and upcoming catalysts — Citi put together a “90‑day catalyst watch” that sees upside despite the outage. Citi Sees Upside
• Positive Sentiment: Technicals may offer support: commentators note shares became oversold after the sell‑off and found support at a prior level, suggesting a possible technical bounce for traders. Stock Of The Day: Where Is The Bottom For Stryker?
• Neutral Sentiment: Stryker has publicly confirmed a cybersecurity incident and is investigating; the company is communicating updates as the situation evolves. Company Announcement
• Neutral Sentiment: Reporting shows the attack is causing real operational disruption to order processing, manufacturing and shipments — facts investors must watch to judge duration and revenue impact. Reuters: Disruption Report
• Negative Sentiment: Hackers claiming Iran linkage (group “Handala”) say the attack included destructive “wiper” activity and exfiltration of large volumes of data — allegations that raise the risk of extended downtime and regulatory/PR fallout. IBTimes: Hacker Claim
• Negative Sentiment: Operational paralysis from the incident has already pressured the stock, with multiple outlets reporting multi‑percent intraday declines as orders and shipments stall. Yahoo: Shares Fall
• Negative Sentiment: Social‑media driven selling amplified volatility — a viral Reddit thread and related headlines accelerated the recent drop, adding short‑term downside risk beyond fundamentals. 24/7 Wall St.: Reddit Impact

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the business's stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director directly owned 2,457,331 shares of the company's stock, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 5.90% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on SYK. Jefferies Financial Group reiterated a "buy" rating and issued a $465.00 price target on shares of Stryker in a research report on Wednesday, March 4th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $435.00 target price on shares of Stryker in a research note on Friday, November 14th. Evercore set a $390.00 target price on shares of Stryker in a report on Monday, January 5th. Robert W. Baird set a $437.00 price target on shares of Stryker in a research report on Friday, January 30th. Finally, Citizens Jmp raised shares of Stryker from a "market perform" rating to an "outperform" rating and set a $440.00 price target for the company in a report on Friday, December 19th. Fourteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Stryker has a consensus rating of "Moderate Buy" and a consensus target price of $428.61.

Stryker Trading Down 0.1%

NYSE:SYK opened at $336.95 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21. The business's 50-day simple moving average is $365.20 and its 200-day simple moving average is $367.71. Stryker Corporation has a fifty-two week low of $328.23 and a fifty-two week high of $404.87. The stock has a market capitalization of $128.95 billion, a PE ratio of 40.11, a price-to-earnings-growth ratio of 1.97 and a beta of 0.85.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.40 by $0.07. The business had revenue of $7.17 billion during the quarter, compared to analysts' expectations of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.Stryker's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business earned $4.01 EPS. Sell-side analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Tuesday, March 31st. Stryker's dividend payout ratio (DPR) is presently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.